This study investigates the effectiveness and safety of an investigational medication for adults with chronic pruritus of unknown origin (CPUO). The study aims to understand how well the investigational medication works in reducing the symptoms of CPUO.The focus of this study is to evaluate the investigational medication's impact on the …
This study investigates the safety and preliminary effectiveness of an investigational medication for adults with advanced solid tumors that cannot be surgically removed or have spread to other parts of the body. The study consists of two parts: a dose escalation phase to find the appropriate dose of the investigational …
This study investigates relapsing forms of multiple sclerosis. The purpose of this study is to measure the annualized relapse rate in adults with this condition.The study will focus on evaluating the safety and effectiveness of an investigational medication compared to an existing treatment. It aims to provide insights into how …
This study investigates nonrelapsing secondary progressive multiple sclerosis (nrSPMS). The purpose of this study is to see how well an investigational medication works in slowing down the progression of disability in people with nrSPMS.Participants will be randomly assigned to receive either the investigational medication or a placebo, which is an …
This study investigates the effects of an investigational medication on children aged 2 to less than 6 years with uncontrolled asthma or severe asthmatic wheeze. The purpose is to understand how this medication can affect these young patients who have difficulty managing their asthma symptoms.The study focuses on evaluating the …
This study investigates the treatment of moderate-to-severe atopic dermatitis in participants aged 12 years and older. The purpose is to evaluate the efficacy and safety of an investigational medication given as a subcutaneous injection, compared to a placebo. Participants will continue using their topical corticosteroids (TCS) during the study. The …
This study investigates the treatment of primary focal segmental glomerulosclerosis (FSGS) and primary minimal change disease (MCD). The study focuses on evaluating the effectiveness and safety of investigational medications compared to a placebo, specifically looking at changes in protein levels in urine and remission rates of nephrotic syndrome.Who can participate: …
This study investigates the long-term safety and efficacy of an investigational medication in adults with asthma. It is an extension of previous studies and will last up to 100 weeks, with participants receiving treatment for up to 96 weeks. The purpose of this study is to continue monitoring the effects …
This study investigates the safety and effectiveness of an investigational medication in adults with relapsed or refractory myeloma.The focus of the study is to evaluate how well the investigational medication works and how safe it is for participants with relapsed or refractory myeloma.Who can participate: Adults with relapsed or refractory …
This study investigates the ability of participants to appropriately select and use an investigational medication for erectile dysfunction using specific labeling and a health survey assessment (HSA). The study will enroll men interested in an over-the-counter treatment for this condition.Participants will enter the study through an open-label process, meaning both …
